{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:21:31Z","timestamp":1778678491156,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","award":["\\u00DANKP-19-3-I-SE-65"],"award-info":[{"award-number":["\\u00DANKP-19-3-I-SE-65"]}],"id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","award":["\\u00DANKP-19-3-I-SE-73"],"award-info":[{"award-number":["\\u00DANKP-19-3-I-SE-73"]}],"id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.lungcan.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T12:29:58Z","timestamp":1583843398000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Attenuated isolated 3\u2019 signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC"],"prefix":"10.1016","volume":"143","author":[{"given":"G\u00e1bor","family":"Smuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Pajor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1roly","family":"Szuhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Morreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildik\u00f3","family":"Kocsm\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9va","family":"Kocsm\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Pajor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Kajt\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"S\u00e1rosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Torn\u00f3czky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2020.03.007_bib0005","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/1535-7163.MCT-07-0365","article-title":"Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma","volume":"6","author":"Los","year":"2007","journal-title":"Mol. Cancer. Therap."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2020.03.007_bib0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1593\/neo.07878","article-title":"EML4-ALK fusion lung cancer: a rare acquired event","volume":"10","author":"Perner","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.lungcan.2020.03.007_bib0020","unstructured":"IASLC Atlas of ALK-ROS1 Testing in Lung Cancer, https:\/\/issuu.com\/iaslc\/docs\/alk-ros1_atlas_low-res."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0025","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1158\/1078-0432.CCR-10-0851","article-title":"Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment","volume":"16","author":"Camidge","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11864-017-0513-x","article-title":"Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS","volume":"18","author":"Niu","year":"2017","journal-title":"Curr. Treat. Option. On."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/annonc\/mdv501","article-title":"Prospective and clinical validation of ALK immunohistochemistry: results from the phase I\/II study of alectinib for ALK-positive lung cancer (AF-001JP study)","volume":"27","author":"Takeuchi","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0040","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/JTO.0000000000000013","article-title":"Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer","volume":"9","author":"Ren","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0045","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/JTO.0b013e3182614ab5","article-title":"Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer","volume":"7","author":"Peled","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jtho.2016.08.145","article-title":"Combinational analysis of FISH and immunohistochemistry reveals rare genomic events in ALK fusion patterns in NSCLC that responds to crizotinib treatment","volume":"12","author":"Li","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0055","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.lungcan.2020.03.007_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/EJE-18-0653","article-title":"Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma","volume":"4","author":"van der Tuin","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0065","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/cncr.28311","article-title":"Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer: implications for ALK inhibitor therapy","volume":"119","author":"Camidge","year":"2013","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2020.03.007_bib0070","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/JTO.0b013e3182286d25","article-title":"Bright-Field Dual-Color Chromogenic In Situ Hybridization for Diagnosing Echinoderm Microtubule-Associated Protein-Like 4-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinomas","volume":"6","author":"Yoshida","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/cyto.a.23489","article-title":"Immense random colocalization, revealed by automated high content image cytometry, seriously questions FISH as gold standard for detecting EML4-ALK fusion","volume":"93","author":"Smuk","year":"2018","journal-title":"Cytometry A."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0080","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0085","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jmoldx.2018.05.007","article-title":"Molecular analysis of gene fusions in bone and Soft tissue tumors by anchored multiplex PCR\u2013Based targeted next-generation sequencing","volume":"20","author":"Lam","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tranon.2018.11.006","article-title":"Discordance between FISH, IHC, and NGS analysis of ALK status in advanced non\u2013small cell lung Cancer (NSCLC): a brief report of 7 cases","volume":"12","author":"Scattone","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/annonc\/mdu484","article-title":"Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK \u2018borderline\u2019-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies","volume":"26","author":"Ilie","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.007_bib0105","doi-asserted-by":"crossref","first-page":"82943","DOI":"10.18632\/oncotarget.12705","article-title":"M. N. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma","volume":"7","author":"Dacic","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2020.03.007_bib0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1634\/theoncologist.2014-0389","article-title":"Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer","volume":"20","author":"Pekar-Zlotin","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2020.03.007_bib0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.lungcan.2015.05.012","article-title":"Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended","volume":"89","author":"Savic","year":"2015","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220303238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220303238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:31:04Z","timestamp":1778675464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500220303238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":23,"alternative-id":["S0169500220303238"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.03.007","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuated isolated 3\u2019 signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}